Crohn's disease (CD) is a chronic, inflammatory, autoimmune disease characterized by transmural inflammatory lesions that affect the entire gastrointestinal tract[@b1]. The clear mechanisms of CD pathogenesis remain to be elucidated. Studies in twins and family members indicate that CD is significantly associated with genetic susceptibility[@b2][@b3]. It has now been accepted that NOD2/CARD15 gene is related to innate immunity in CD[@b4][@b5]. Furthermore, genes of ATG16L1[@b6] and IRGM[@b7][@b8] have been recognized to play pivotal roles in autophagy in CD. However, these genetic variants can not fully explain the disease onset of CD. To date, genome-wide association studies have identified approximately 80 CD-susceptibility loci, indicating a series of genes and pathogenic mechanisms, such as microbe recognition, lymphocyte activation, cytokine signaling and intestinal epithelial defense[@b9][@b10][@b11]. Thus, genetic association studies provide a foundation for the immunopathogenesis for the disease, implicating the role of innate and adaptive immunity in CD occurrence.

Interleukin-23 (IL-23), an important immuno-regulatory cytokine secreted by activated macrophages and dendritic cells, regulates the differentiation of T helper 17 cells from native CD4+ T cells[@b12]. Binding to IL-23 receptor (IL-23R) complex, IL-23 performed significantly through the Janus kinase (JAK)-signal transducer and activator of transcription (STAT) and NF-κB signaling pathways[@b13][@b14]. The proportion of IL-23R-expressing T cells in the periphery was 2-fold higher in ankylosing spondylitis (AS) patients than in healthy controls, specifically driven by a 3-fold increase in IL-23R-positive γ/δ T cells in AS patients[@b15]. γ/δ T cells from AS patients were skewed toward IL-17 production in response to stimulation with IL-23. In IL-23R reporter mice, γ/δ T cells responded to IL-23 during experimental autoimmune encephalomyelitis. IL-23-activated γ/δ T cells rendered αβ effector T cells refractory to the suppressive activity of regulatory T (Treg) cells and also prevented the conversion of conventional T cells into Foxp3(+) Treg cells, suggesting that IL-23/IL23R may play a potential role in autoimmune diseases[@b16]. IL-23/IL23R signaling plays critical roles in innate and adaptive inflammatory responses in the intestinal mucosa[@b17]. In mice models, IL-23/IL-23R, a key component of IL-23/Th17 pathway, is essential for intestinal inflammation of T cell-dependent colitis[@b18][@b19]. Furthermore, patients with CD manifested increased IL-23 secretion compared with controls[@b20]. A genome-wide association study indicated that IL-23R gene is a potential candidate for CD susceptibility[@b21]. IL-23R gene is mapped to the chromosome 1 (1p31.3)[@b13]. Recently, polymorphisms in this locus have been identified and a large number of studies indicated the association between these polymorphisms and CD risk[@b21][@b22][@b23][@b24][@b25][@b26][@b27][@b28][@b29][@b30][@b31][@b32][@b33][@b34][@b35][@b36][@b37][@b38][@b39][@b40][@b41][@b42][@b43][@b44][@b45][@b46][@b47][@b48][@b49][@b50][@b51][@b52][@b53][@b54][@b55][@b56][@b57][@b58][@b59][@b60][@b61][@b62][@b63][@b64][@b65][@b66][@b67][@b68][@b69][@b70][@b71][@b72][@b73][@b74][@b75][@b76]. However, previous studies in different populations reported conflicting results. The disaccord may be attributed to small sample size, various racial and ethnic backgrounds, uncorrected multiple hypothesis testing and publication bias.

Meta-analysis is a statistical method for augmenting the effective sample size through combining the results of several studies to produce a single estimate of the major effect with enhanced precision. It is considered to be a powerful tool for pooling inconsistent results from different studies[@b77]. To date, two meta-analysis[@b52][@b78] of the association between the IL-23R gene polymorphisms and CD risk have been reported, but these results were still inconclusive. New studies about the role of these SNPs in the IL-23R gene in CD have been published in recent years[@b53][@b54][@b55][@b56][@b57][@b58][@b59][@b60][@b61][@b62][@b63][@b64][@b65][@b66][@b67][@b68][@b69][@b70], and these studies might provide new evidence. Thus, it seems necessary to perform an updated and comprehensive meta-analysis including the latest data to investigate the association of the IL-23R gene polymorphisms and the risk of CD.

Materials and Methods
=====================

Publication research
--------------------

A literature search was conducted for studies that examined association between the IL-23R gene polymorphisms and CD risk in October 13, 2015. We used PubMed database, Elsevier Science Direct, China National Knowledge Infrastructure database (CNKI) and Chinese Biomedical database (CBM) to identify articles with the following terms: "Interleukin-23 receptor, IL-23R, Crohn's disease, Crohn disease, inflammatory bowel disease, CD and IBD". References in the studies were also reviewed to find additional studies. The languages were limited to English and Chinese.

Inclusion and exclusion criteria
--------------------------------

A study was included in the analysis if a) it was a case-control or cohort study; b) it included original data (independence among studies); and c) it provided sufficient data to calculate the odds ratio (OR). We excluded the followings: a) studies contained overlapping data; b) studies in which family members had been studied because of the analysis based on linkage considerations.

Data extraction
---------------

Data were collected by two independent investigators (Qi-Bing Xie and Yi Zhao). The characteristics of the selected articles were in [Table 1](#t1){ref-type="table"}, including first author, year of publication, study population, ethnicity, numbers of case and control, genotyping method, the concrete polymorphisms investigated in these studies. The study populations comprised Italian, German, Dutch, Hungarian, Korean, Chinese, Malaysian, African American, Australian, Canadian, Algerian and so on. The Asian subgroup included Korean, Chinese, and Malaysian populations. African American population was classified in the African subgroup and others in the Caucasian subgroup.

Statistical analysis
--------------------

Allele frequencies at the IL-23R gene polymorphisms from the respective study were determined by the allele counting method. The contrast of the allelic effect of minor allele versus common allele of the IL-23R gene polymorphisms was tested. The strength of association between the IL-23R gene polymorphisms and CD susceptibility was assessed by odds ratios (OR) and 95% confidence intervals (95% CI).

The heterogeneity of between-studies was evaluated by the Chi-square test based Q-statistic[@b79]. In addition, the I^2^-statistic also measures the degree of inconsistency in the studies by computing what percentage of the total variation across studies was due to heterogeneity rather than by chance. A high value of I^2^ indicated a higher probability of the existence of heterogeneity (I^2^ = 0% to 25%, no heterogeneity; I^2^ = 25% to 50%, moderate heterogeneity; I^2^ = 50% to 75%, large heterogeneity; and I^2^ = 75% to 100%, extreme heterogeneity). If a *P*-value of the heterogeneity Q-statistic was more than 0.10, the pooled OR was calculated by the fixed effects model. Otherwise, a random effects model was adopted. Potential publication bias was analyzed by Egger's linear regression test and the Funnel plot. If *P*-value was less than 0.05, statistically significant publication bias might exist[@b80].

All the statistical analysis of meta-analysis was performed by STATA statistical software (version 11.0 STATA Corp LP, College Station, TX, USA).

Results
=======

Study characteristics
---------------------

The process for selecting the studies was shown in [Fig. 1](#f1){ref-type="fig"}. 424 potentially relevant records were first reviewed, and 56 articles met the inclusion criteria were finally included in themeta-analysis[@b21][@b22][@b23][@b24][@b25][@b26][@b27][@b28][@b29][@b30][@b31][@b32][@b33][@b34][@b35][@b36][@b37][@b38][@b39][@b40][@b41][@b42][@b43][@b44][@b45][@b46][@b47][@b48][@b49][@b50][@b51][@b52][@b53][@b54][@b55][@b56][@b57][@b58][@b59][@b60][@b61][@b62][@b63][@b64][@b65][@b66][@b67][@b68][@b69][@b70][@b71][@b72][@b73][@b74][@b75][@b76]. Among the 56 articles, 4 were published in Chinese and the others in English. Of the 56 articles, one article included three cohorts[@b24], other two[@b21][@b68] included two cohorts, thus, each cohort was considered as a single study. Finally, a total of 60 case-control studies in 56 articles involving 22,820 CD patients and 27,401 healthy controls were identified. There were 49 studies on rs11209026, 25 studies on rs7517847, 19 studies on rs2201841 and rs1004819 separately, 18 studies on rs10889677, 15 studies on rs1343151 and rs1495965 separately, 13 studies on rs11209032, 12 studies on rs10489629 and 8 on rs11465804. Forty-nine studies involved Caucasian populations[@b21][@b22][@b23][@b24][@b25][@b26][@b27][@b28][@b29][@b30][@b31][@b32][@b33][@b34][@b35][@b36][@b37][@b38][@b39][@b40][@b41][@b42][@b43][@b44][@b45][@b46][@b47][@b48][@b49][@b50][@b51][@b52][@b53][@b54][@b55][@b56][@b57][@b58][@b59][@b60][@b61][@b62][@b63][@b64][@b66][@b67][@b68][@b69], nine studies involved Asian populations[@b34][@b51][@b61][@b70][@b71][@b72][@b73][@b74][@b75], and two study involved African populations[@b65][@b76]. The main characteristics of each study included in this meta-analysis were summarized in [Table 1](#t1){ref-type="table"}.

Evaluation of heterogeneity and publication bias
------------------------------------------------

Between-study heterogeneity was found in some meta-analysis of the IL-23R gene polymorphisms in CD ([Table 2](#t2){ref-type="table"}). Therefore, these meta-analyses were performed in a random effects model, and the other meta-analyses were done in a fixed effects model.

The funnel plot asymmetry and Egger's test were performed to assess potential publication bias. If there was asymmetry, the index to determine Egger's test will show *P* \< 0.05. It was shown that there was no significant publication bias between all of the comparisons (all *P*-value \> 0.05).

Meta-analysis of IL-23R gene polymorphisms in Crohn's disease
-------------------------------------------------------------

A summary of the meta-analysis of the association between the IL-23R gene polymorphisms and CD was listed in [Table 2](#t2){ref-type="table"}.

IL-23R rs7517847, rs1343151, rs10489629 polymorphisms and CD
------------------------------------------------------------

Twenty-five studies determined the relationship between the rs7517848G/T polymorphism and CD risk[@b21][@b22][@b25][@b27][@b30][@b31][@b34][@b35][@b36][@b41][@b42][@b43][@b47][@b48][@b49][@b54][@b59][@b60][@b63][@b64][@b65][@b68][@b73]. The total sample size for patients with CD and healthy controls was 9,297 and 12,643, respectively. Meta-analysis revealed an association between the rs7517847G allele and CD risk in the overall population (OR = 0.699, 95% CI = 0.659 \~ 0.741, *P* \< 0.001; [Fig. 2](#f2){ref-type="fig"}). Stratification by ethnicity indicated that the rs7517847G allele was significantly associated with CD risk in the Caucasian population (OR = 0.669, 95% CI = 0.641 \~ 0.698, *P* \< 0.001), but not in the other subgroups. Meta-analysis of the rs1343151 and rs10489629 polymorphisms showed the same pattern as for rs7517847. Minor alleles of all polymorphisms might be protective alleles for CD susceptibility in Caucasians, but not in the other populations ([Table 2](#t2){ref-type="table"}).

IL-23R rs10889677, rs1004819, rs1495965, rs11209032 polymorphisms and CD
------------------------------------------------------------------------

Eighteen studies containing 7,518 cases and 8,671 healthy controls examined the association of rs10889677A/C and CD[@b21][@b22][@b26][@b27][@b30][@b33][@b34][@b36][@b40][@b43][@b51][@b54][@b63][@b64][@b65][@b68][@b72]. Results indicated a significant association between the rs100889677A/C polymorphism and CD (OR = 1.393, 95% CI = 1.328 \~ 1.461, *P* \< 0.001; [Fig. 3](#f3){ref-type="fig"}). Stratifying by ethnicity, we found a significant association in the Caucasian population (OR = 1.438, 95% CI = 1.366 \~ 1.513, *P* \< 0.001; [Fig. 2](#f2){ref-type="fig"}). Results by meta-analysis of the rs1004819, rs1495965 and rs11209032 polymorphisms revealed the same pattern as for rs10889677. Minor alleles of the SNPs above might be risk alleles for CD in Caucasian subgroup. Detail results were presented in [Table 2](#t2){ref-type="table"}.

IL-23R rs2201841, rs11209026, rs11465804 polymorphisms and CD
-------------------------------------------------------------

Eighteen case-control studies including 6,846 cases and 9,056 healthy controls identified a significant association between the rs2201841C/T polymorphism and susceptibility to CD[@b21][@b22][@b25][@b26][@b27][@b34][@b35][@b40][@b43][@b51][@b53][@b63][@b64][@b65][@b68][@b73]. The pooled OR (95% CI, P value) in the C versus T allele was 1.368 (1.301 \~ 1.438, *P* \< 0.001). Ethnicity-specific analysis showed that the rs2201841C allele was significantly associated with CD in the Caucasian and African subjects (OR = 1.413, 95% CI = 1.338 \~ 1.491, *P* \< 0.001; OR = 1.392, 95% CI = 1.042 \~ 1.858, *P* = 0.025, respectively). The forest plot was shown in [Fig. 4](#f4){ref-type="fig"}. Meta-analysis of the rs11209026 polymorphism showed the same pattern as for rs2201841. In addition, a significant association was found between the rs11465804G allele and the risk of CD in Caucasians (OR = 0.435, 95% CI = 0.376 \~ 0.503, *P* \< 0.001) ([Table 2](#t2){ref-type="table"}). However, Asians and Africans-based subgroup analysis were not performed.

Discussion
==========

A genome-wide association study by Duerr *et al.*[@b21] found strong correlation between IL-23R polymorphisms and inflammatory bowel disease (IBD). Since then, genetic variants of IL-23R have been investigated in numerous autoimmune diseases. It has been shown that the IL-23R gene plays an important role in the pathogenesis of some autoimmune diseases, such as IBD, AS, psoriasis, rheumatoid arthritis, and multiple sclerosis[@b81]. Oliver *et al.*[@b30] and Baptista *et al.*[@b36] found rs11209026, rs10889677 and rs1004819 polymorphisms were associated with CD disease susceptibility in Spanish. Similarly, a study on Hungarian with CD revealed that the rs1004819T carrier (TT + TC) had a 53% increasing risk when compared with the CC homozygote[@b53]. Furthermore, a study in Korean population indicated that the rs1495965G allele frequency was higher in CD cases compared to controls (OR = 1.31, 95% CI = 1.07 \~ 1.60)[@b51]. However, Okazaki *et al.*[@b43] and Chua *et al.*[@b61] found no significant differences in allele or genotype frequency of rs11209026 and rs1004819 polymorphisms between CD patients and controls in a Malaysian population.

Therefore, to better comprehend the association between polymorphisms in the IL-23R gene and CD susceptibility, a pooled analysis with a larger sample size, subgroup analysis performed and heterogeneity explored is needed. Overall, results of this meta-analysis suggested that IL-23R gene polymorphisms were associated with CD susceptibility (all *P* value \< 0.001). Ethnicity-specific analysis showed that the polymorphisms in the IL-23R gene might confer susceptibility to CD in Caucasians, but not in Asians.

The diverse roles of the same gene polymorphism in ethnicity-specific analysis by ethnicity could be ascribed to the following major aspects. First, Yamazaki *et al.*[@b34] showed that IL-23R gene was not a candidate gene to CD in the Japanese population. Furthermore, Lee *et al.*[@b82] found that rs1004819, rs10489629, rs1343151, rs1495965, rs11209032 and rs2201841 polymorphisms revealed a different association with ankylosing spondylitis between Caucasians and Asians. Compared to the populations of Caucasian, no significant association was detected for IL-23R polymorphisms in Chinese psoriasis patients[@b83]. Similarly, IL-23R (rs1004819, rs7517847, rs10489629, rs2201841, rs1343151, rs11209032, and rs1495965) polymorphisms were not associated with systemic lupus erythematosus (SLE) in the Korean population[@b84], while rs10889677 and rs7517847 polymorphisms were not associated with Chinese SLE patients[@b85]. In addition, CD is the most prevalent in North America and Europe, and the least prevalent among African Americans and Asians[@b86]. These findings suggested that IL-23R gene might have a susceptible nature in the Caucasians, but not in the Asians. Therefore, the inconsistent results of subgroup analysis might be attributed to ethnic differences. Second, for other variants in the IL-23R gene, Zhao *et al.*[@b75] found that IL-23R rs11805303 and rs17375018 polymorphisms were not associated with CD disease susceptibility in Chinese. Similarly, a study in another Chinese population showed no significant differences in allele or genotype frequency of the rs11805303 polymorphism between CD patients and controls[@b71]. However, Chen *et al.*[@b72] found that the rs11465788T allele frequency was lower in Chinese CD cases compared to controls (OR = 0.30, 95%CI = 0.15--0.60). Since few studies in Asian population focus on these polymorphisms, these results might not be reliable. Therefore, large sample size GWAS should be considered in future to confirm the role of these variants in the IL-23R gene in Asians. Third, most autoimmune diseases including CD are multifactor diseases, and these diseases were caused by an interaction of genetic and environmental factors[@b87]. Therefore, different populations lived in different environments, gene-environment interactions may partly affect the autoimmune diseases susceptibility. It has been widely accepted that genetic and environmental factors play an important role in disease initiation such as SLE, and the progression of the disease. A previous study has confirmed that the IFIH1 rs1990760 polymorphism was associated with SLE in the European population, not in the Asian population[@b88], suggesting that interactions between different environments and genes might be different.

Although the IL-23R gene is associated with CD risk, the function of IL-23R gene variants remains unclear. Several possible mechanisms can be suggested by which polymorphisms can regulate the function of the IL-23R gene. First, the standard form of IL-23R is encoded by at least 12 exons. Zhang *et al.*[@b89] demonstrated that at least six spliced isoforms of IL-23R (IL-23R1 to 6) can be generated through alternative splicing. Translation prediction revealed that spliced variants led to either premature termination to give rise to a diverse form of receptor ectodomain, or a frameshift to generate various lengths of the IL-23R endodomain[@b89]. Furthermore, the intronic polymorphisms, such as rs11805303, rs1004819, might exert their influence by regulating differential splicing. Second, the rs11209026 polymorphism, also named as Arg381Gln, is located between the transmembrane domain and the putative JAK2 binding site in the cytoplasmic portion of IL23R protein and highly conserved between species[@b90]. Replacing conserved Arg381 for Gln381 at this position probably modulates IL-17 and IL-22 expression in response to IL-23 stimulation, which may have a functional influence on IL-23R signaling pathway[@b91][@b92]. Third, the rs10889677 polymorphism, located in the 3′-UTR, might promote overexpression of the receptor through increasing mRNA stability and driving T cells to differentiate towards Th17, and thus, leading to inflammation by increasing release of other cytokines[@b81]. Forth, the rs10889677 variant enhanced both mRNA and protein expression of IL-23R can lead to a loss of binding capacity to the microRNAs (miRNAs) Let-7e and Let-7f. MiRNA-mediated dysregulation of IL-23R signaling correlated with a single nucleotide polymorphism in the IL-23R gene was strongly associated with CD susceptibility, suggesting that this mutation can lead to altered IL-23R signaling[@b93].

With respect to the IL-23R haplotypes and CD, Taylor *et al.*[@b94] showed that haplotype TA (rs1004819 (T) + rs790631 (A)) was 55.4% in the controls, and 64% in CD patients (P = 0.019), indicating a haplotype inferring increased CD risk. Similarly, haplotype CACCGC (rs7530511 (C) + rs7528924 (A) + rs2201841 (C) + rs10489628 (C) + rs11209026 (G) + rs1343151 (C)) was 55.8% in the controls, and 64.4% in CD patients (P = 0.013), indicating a "risk" haplotype. On the contrary, haplotype GA (rs1004819 (G) + rs790631 (A)) was 64.5% in the control group, and 54.4% in CD patients (P = 0.006), suggesting a haplotype inferring decreased CD risk. Similarly, haplotype CATTGT (rs7530511 (C) + rs7528924 (A) + rs2201841 (T) + rs10489628 (T) + rs11209026 (G)+ rs1343151 (T)) was 47.0% in the controls, and 36.6% in CD patients (P = 0.001), suggesting a "protective" haplotype. In addition, Szabo *et al.*[@b64] found that haplotype GTTTAC (rs1004819 (G) + rs7517847 (T) + rs7530511 (T) + rs2201841 (T) + rs1343151 (A) + rs10889677 (C)) showed a strong protective effect in CD, and it reduced disease risk (OR = 0.37, 95% CI = 0.17 \~ 0.78, *P* = 0.009). Furthermore, Doecke *et al.*[@b68] reported that haplotype GG (rs1004819 (G) + rs7517847 (G)) was negatively related to CD risk (OR = 0.71, 95% CI = 0.62 \~ 0.81, *P* \< 0.001). However, haplotype AT (rs1004819 (G) + rs7517847 (G)) was positively related to CD risk (OR = 1.45, 95% CI = 1.26 \~ 1.67, *P* \< 0.001).

Compared with the previous meta-analysis[@b52][@b78], the current study involved a total of 60 case-control studies in 56 articles, which is much larger than the data of the previous meta-analysis. Moreover, we performed subgroup analysis by ethnicity to discuss the ethnic effect on the risk of CD. Thus, our meta-analysis might enhance the statistical power and draw a more reliable conclusion.

Some limitations of the present study should be considered. First, we could not analyze the potential gene-environment interactions and gene susceptibility haplotypes owing to lack of data, such as the data of environmental risk factors and genotypes. Second, our literature search was only dependent on English and Chinese, language bias might be considered. Third, potential publication bias was not found by statistical method, but it might exist because of only published articles included. Fourth, only one published studies in the African origin was included in the meta-analysis, the stratified analysis for Africans might not be reliable. Thus, the results were applicable only to the Asian and Caucasian groups. Finally, different genotyping methods and disease status might affect the data interpretation of the included studies.

In summary, the current study provides a comprehensive examination of the available evidence for the association between polymorphisms in the IL-23R gene and CD. This updated meta-analysis suggests that IL-23R gene polymorphisms are associated with CD susceptibility. However, larger sample size studies taking environmental risk factors into account and including more ethnic groups should be considered in future to confirm the results from our meta-analysis.
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###### Characteristics of the individual studies included in the meta-analysis.

  First Author                 Year      Population (Ethnicity)    Numbers                        Genotyping Methods                                                                IL-23R polymorphisms studied
  ------------------------ ------------ ------------------------ ------------ ---------------------------------------------------------- -------------------------------------------------------------------------------------------------------------------
  Duerr[@b21]                  2006          Non-Jewish (C)        547/548                            Sequencing                                                      rs1004819, rs7517847, rs10489629, rs2201841, rs11465804,
                            Jewish (C)          401/433           Sequencing   rs11209026, rs1343151, rs10889677, rs11209032, rs1495965  
  Baldassano[@b22]             2007           American (C)         142/281                            Sequencing                          rs1004819, rs7517847, rs10489629, rs2201841, rs11465804, rs11209026, rs1343151, rs10889677, rs11209032, rs1495965
  Borgiani[@b23]               2007           Italian (C)          187/194                              TaqMan                                                                               rs11209026
  Bunning[@b24]                2007            German (C)          318/428                               PCR                                                                                 rs11209026
                                             Hungarian (C)         148/200                               PCR                                                                                 rs11209026
                                               Dutch (C)           157/217                               PCR                                                                                 rs11209026
  Cummings[@b25]               2007           British (C)          604/1149                           Sequencing                                      rs1004819, rs7517847, rs10489629, rs2201841, rs11209026, rs1343151, rs11209032, rs1495965
  Farago[@b26]                 2007          Hungarian (C)         190/220                             PCR-RFLP                                                                         rs10889677, rs2201841
  Glas[@b27]                   2007            German (C)          833/1381                              PCR                              rs1004819, rs7517847, rs10489629, rs2201841, rs11465804, rs11209026, rs1343151, rs10889677, rs11209032, rs1495965
  Leshinsky-Silver[@b28]       2007           Israeli (C)          282/157                               PCR                                                                                 rs11209026
  Limbergen[@b29]              2007          Scotchman (C)         233/342                              TaqMan                                                                               rs11209026
  Oliver[@b30]                 2007           Spanish (C)          238/342                              TaqMan                                       rs1004819, rs7517847, rs10489629, rs11209026, rs1343151, rs10889677, rs11209032, rs1495965
  Rioux[@b31]                  2007           American (C)         988/1007                           Sequencing                                                                              rs7517847
  Roberts[@b32]                2007        New Zealander (C)       496/591                              TaqMan                                                                               rs11209026
  Tremelling[@b33]             2007           British (C)         1902/1345                           Sequencing                                     rs1004819, rs10489629, rs11465804, rs11209026, rs1343151, rs10889677, rs11209032, rs1495965
  Yamazaki[@b34]               2007           Japanese (A)         484/439                         TaqMan PCR-RFLP                        rs1004819, rs7517847, rs10489629, rs2201841, rs11465804, rs11209026, rs1343151, rs10889677, rs11209032, rs1495965
  Amre[@b35]                   2008           Canadian (C)         259/139                              FP-SBE                            rs1004819, rs11209026, rs7517847, rs10489629, rs2201841, rs11465804, rs1343151, rs10889677, rs11209032, rs1495965
  Baptista[@b36]               2008          Brazilian (C)         187/255                              TaqMan                                                         rs1004819, rs7517847, rs11209026, rs1495965, rs10889677
  Civitavecchia[@b37]          2008           Italian (C)          199/100                            Sequencing                                                                             rs11209026
  Gaj[@b38]                    2008            Polish (C)           60/139                              TaqMan                                                                               rs11209026
  Lakatos[@b39]                2008          Hungarian (C)         266/149                               PCR                                                                                 rs11209026
  Lappalainen[@b40]            2008           Finnish (C)          238/292                               PCR                                         rs1004819, rs10489629, rs2201841, rs11465804, rs11209026, rs1343151, rs10889677, rs11209032
  Latiano[@b41]                2008           Italian (C)          723/716                              TaqMan                                                                          rs11209026, rs7517847
  Lu[@b74]                     2008           Chinese (A)           74/100                               PCR                                                                                 rs11209026
  Marquez[@b42]                2008           Spanish (C)          344/547                              TaqMan                                                                          rs11209026, rs7517847
  Okazaki[@b43]                2008           Canadian (C)         213/310                              TaqMan                                                         rs7517847, rs2201841, rs11209026, rs10889677, rs1495965
  Venegas[@b44]                2008           Chilean (C)           38/58                              PCR-RFLP                                                                              rs11209026
  Weersma[@b45]                2008            Dutch (C)          1684/1350                             TaqMan                                                                               rs11209026
  Chen[@b71]                   2008           Chinese (A)           41/50                                PCR                                                                                 rs11209026
  Dusatkova[@b46]              2009            Czech (C)           333/499                              TaqMan                                                                               rs11209026
  Chen[@b72]                   2009           Chinese (A)           50/50                             Sequencing                                                                             rs10889677
  Feng[@b73]                   2009           Chinese (A)           96/96                             Sequencing                                                                   rs1004819, rs7517847, rs2201841
  Lacher[@b47]                 2009            German (C)          221/253                              TaqMan                                                                          rs11209026, rs7517847
  Mitrovi[@b48]                2009          Slovenian (C)         159/345                             PCR-RFLP                                                                               rs7517847
  Newman[@b49]                 2009           Canadian (C)         443/1005                           Sequencing                                                                        rs11209026, rs7517847
  Weersma[@b50]                2009        Dutch-Belgian (C)      1656/1086                           Sequencing                                                                             rs11209026
  Yang[@b51]                   2009            Korean (A)          380/380                            Sequencing                                                       rs1004819, rs2201841, rs11209026, rs10889677, rs1495965
  Cotterill[@b52]              2009           British (C)          295/877                            Sequencing                                                                             rs11209026
  Csöngei[@b53]                2010          Hungarian (C)         315/314                             PCR-RFLP                                                                         rs1004819, rs2201841
  Ferguson[@b54]               2010        New Zealander (C)       339/407                              TaqMan                                                              rs10889677, rs11209026, rs1343151, rs7517847
  Gazouli[@b55]                2010            Greek (C)           474/539                               PCR                                                                                 rs11209026
  Mahurkar[@b56]               2010            Indian (C)          241/442                            Sequencing                                                                             rs11209026
  Sventoraityte[@b57]          2010          Lithuanian (C)         57/186                              TaqMan                                                                               rs11209026
  Wagner[@b58]                 2010          Australian (C)         72/98                                PCR                                                                                 rs11209026
  Lauriola[@b59]               2010           Italian (C)           19/20                                PCR                                                                            rs11209026, rs7517847
  Peter[@b60]                  2011          Ashkenazi (C)         369/503                              TaqMan                                                                          rs11209026, rs7517847
  Zhao[@b75]                   2011           Chinese (A)           43/134                             SNaPshot                                                                         rs1343151, rs11209032
  Chua[@b61]                   2012          Malaysian (A)          80/100                             PCR-RFLP                                                                               rs1004819
  Jung[@b62]                   2012            Franch (C)          798/960                            Sequencing                                                                             rs11209026
  Safrany[@b63]                2012          Hungarian (C)         199/253                             PCR-RFLP                                                             rs7517847, rs2201841, rs10889677, rs11209032
  Szabo[@b64]                  2012          Hungarian (C)         190/182                             PCR-RFLP                                                        rs1004819, rs7517847, rs2201841, rs1343151, rs10889677
  Wang[@b65]                   2012         African American       354/354                              TaqMan                                                         rs7517847, rs2201841, rs11209026, rs1496965, rs10889677
  Mihaljevi[@b66]              2013           Croatian (C)          50/99                                PCR                                                                                 rs11209026
  Ballester[@b67]              2013         Puerto Rican (C)       406/504                            Sequencing                                                                             rs11209026
  Doecke[@b68]                 2014          Australian (C)        675/1255                           Sequencing                          rs1004819, rs7517847, rs10489629, rs2201841, rs11465804, rs11209026, rs1343151, rs10889677, rs11209032, rs1495965
                                           New Zealander (C)       318/533                            Sequencing                                                 rs1004819, rs7517847, rs10489629, rs2201841, rs11209026, rs1343151
  Meddour[@b69]                2014           Algerian (C)         204/201                              TaqMan                                                                               rs11209026
  Zhang[@b70]                  2014           Chinese (A)          420/450                              TaqMan                                                                    rs11209026, rs1004819, rs1495965
  Huang[@b76]                  2015         African American      1088/1797                           Immunochip                                                                             rs11209026

CD: Crohn's disease, C: Caucasian, A: Asian.

###### Meta-analysis of IL-23R polymorphisms in CD.

  Polymorphisms           Population   No. of studies          Test of association     Test of heterogeneity   Egger's test (*p*)                                       
  ----------------------- ------------ ----------------------- ----------------------- ----------------------- -------------------- ------- --------- --------- ------- -------
  rs11209026 A versus G   Overall      49                      0.407(0.378 \~ 0.439)   23.32                   \<0.001              R       75.51     0.007     36.4    0.420
  Caucasian               44           0.406(0.365 \~ 0.452)   16.50                   \<0.001                 R                    67.45   0.010     36.2      0.606   
  Asian                   3            0.659(0.409 \~ 1.063)   1.71                    0.087                   F                    0.47    0.791     0         0.059   
  African                 2            0.584(0.375 \~ 0.911)   2.37                    0.018                   F                    1.00    0.318     0         NA      
  rs7517847 G versus T    Overall      25                      0.699(0.659 \~ 0.741)   11.93                   \<0.001              R       46.18     0.004     48.0    0.303
  Caucasian               22           0.669(0.641 \~ 0.698)   18.68                   \<0.001                 F                    26.22   0.198     19.9      0.545   
  Asian                   2            0.896(0.773 \~ 1.039)   1.46                    0.145                   F                    0.42    0.517     0         NA      
  African                 1            0.940(0.726 \~ 1.216)   0.47                    0.637                   NA                   NA      NA        NA        NA      
  rs10889677 A versus C   Overall      18                      1.393(1.328 \~ 1.461)   13.65                   \<0.001              F       21.98     0.185     22.7    0.165
  Caucasian               15           1.438(1.366 \~ 1.513)   13.96                   \<0.001                 F                    9.32    0.810     0         0.196   
  Asian                   2            1.098(0.945 \~ 1.276)   1.22                    0.222                   F                    0.75    0.385     0         NA      
  African                 1            1.220(0.916 \~ 1.626)   1.36                    0.174                   NA                   NA      NA        NA        NA      
  rs1004819 T versus C    Overall      19                      1.352(1.264 \~ 1.446)   8.82                    \<0.001              R       35.77     0.008     49.7    0.158
  Caucasian               14           1.441(1.373 \~ 1.514)   14.68                   \<0.001                 F                    8.73    0.793     0         0.943   
  Asian                   5            1.102(0.994 \~ 1.222)   1.84                    0.066                   F                    5.86    0.210     31.8      0.242   
  rs2201840 C versus T    Overall      18                      1.368(1.301 \~ 1.438)   12.33                   \<0.001              F       19.28     0.313     11.8    0.342
  Caucasian               14           1.413(1.338 \~ 1.491)   12.53                   \<0.001                 F                    7.56    0.871     0         0.617   
  Asian                   3            1.088(0.943 \~ 1.255)   1.15                    0.250                   F                    0.53    0.769     0         0.996   
  African                 1            1.392(1.042 \~ 1.858)   2.24                    0.025                   NA                   NA      NA        NA        NA      
  rs1343151 T versus C    Overall      15                      0.725(0.690 \~ 0.763)   12.49                   \<0.001              F       19.03     0.164     26.4    0.576
  Caucasian               13           0.717(0.681 \~ 0.755)   12.73                   \<0.001                 F                    11.97   0.448     0         0.842   
  Asian                   2            1.069(0.790 \~ 1.444)   0.43                    0.667                   F                    0.47    0.494     0         NA      
  rs1495965 G versus A    Overall      15                      1.197(1.103 \~ 1.299)   4.29                    \<0.001              R       43.42     \<0.001   67.8    0.129
  Caucasian               12           1.218(1.111 \~ 1.335)   4.20                    \<0.001                 R                    34.76   \<0.001   68.4      0.180   
  Asian                   3            1.119(0.945 \~ 1.324)   1.31                    0.191                   R                    4.75    0.093     57.9      0.354   
  rs11209032 A versus G   Overall      13                      1.343(1.279 \~ 1.411)   11.73                   \<0.001              F       11.51     0.485     0       0.182
  Caucasian               11           1.359(1.291 \~ 1.431)   11.68                   \<0.001                 F                    9.16    0.517     0         0.308   
  Asian                   2            1.181(0.995 \~ 1.403)   1.90                    0.057                   F                    0.02    0.885     0         NA      
  rs10489629 G versus A   Overall      12                      0.791(0.706 \~ 0.887)   4.02                    \<0.001              R       56.15     \<0.001   80.4    0.220
  Caucasian               11           0.775(0.690 \~ 0.869)   4.33                    \<0.001                 R                    48.83   \<0.001   79.5      0.310   
  Asian                   1            0.998(0.815 \~ 1.222)   0.02                    0.986                   NA                   NA      NA        NA        NA      
  rs11465804 G versus T   Overall      8                       0.435(0.376 \~ 0.503)   11.18                   \<0.001              F       6.29      0.506     0       0.082
  Caucasian               8            0.435(0.376 \~ 0.503)   11.18                   \<0.001                 F                    6.29    0.506     0         0.082   

CD: Crohn's disease, R: random effects model, F: fixed effects model, NA: not available.
